ARCH BIOPARTNERS INC (ARCH.CA) Stock Overview
TSX-V:ARCH - CA03938C1041 - Common Stock
ARCH.CA Key Statistics, Chart & Performance
The current stock price of ARCH.CA is 1.68 CAD. In the past month the price decreased by -0.59%. In the past year, price increased by 15.86%.
ARCH.CA Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| IOT.CA | INNOVOTECH INC | 24 | 12.04M |
Related stock screener links
About ARCH.CA
Company Profile
Arch Biopartners, Inc. is a portfolio-based biotechnology company, which engages in the development of technologies that have the potential to make a significant medical or commercial impact. The company is headquartered in Toronto, Ontario. The firm is developing a platform of novel drugs targeting the dipeptidase-1 (DPEP1) inflammation pathway prevalent in the kidneys, lungs and liver. The firm is advancing a pipeline of drug candidates that includes LSALT peptide, a first-in-class inhibitor of the DPEP1 inflammation pathway, and cilastatin, a repurposed drug with off-target effects that help block toxin uptake into the kidneys - two approaches addressing distinct and urgent causes of AKI. The firm is ongoing Phase II international multi-center, randomized, double-blind, placebo-controlled study of LSALT peptide targeting cardiac surgery-associated acute kidney injury (CS-AKI). Cilastatin is particularly suited to preventing AKI caused by exogenous and endogenous toxins due to an off-target effect that blocks their uptake into the kidney tissue.
Company Info
ARCH BIOPARTNERS INC
545 King St W.
TORONTO ONTARIO M5V 1M1 CA
CEO: Richard Muruve
Employees: 0
Phone: 16474287031
ARCH BIOPARTNERS INC / ARCH.CA FAQ
What is the stock price of ARCH BIOPARTNERS INC today?
The current stock price of ARCH.CA is 1.68 CAD. The price increased by 1.2% in the last trading session.
What is the ticker symbol for ARCH BIOPARTNERS INC stock?
The exchange symbol of ARCH BIOPARTNERS INC is ARCH and it is listed on the TSX Venture Exchange exchange.
On which exchange is ARCH.CA stock listed?
ARCH.CA stock is listed on the TSX Venture Exchange exchange.
What is the price forecast or stock price prediction for ARCH BIOPARTNERS INC stock?
7 analysts have analysed ARCH.CA and the average price target is 3.57 CAD. This implies a price increase of 112.5% is expected in the next year compared to the current price of 1.68. Check the ARCH BIOPARTNERS INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is ARCH BIOPARTNERS INC worth?
ARCH BIOPARTNERS INC (ARCH.CA) has a market capitalization of 111.06M CAD. This makes ARCH.CA a Micro Cap stock.
How many employees does ARCH BIOPARTNERS INC have?
ARCH BIOPARTNERS INC (ARCH.CA) currently has 0 employees.
What are the support and resistance levels for ARCH BIOPARTNERS INC (ARCH.CA) stock?
ARCH BIOPARTNERS INC (ARCH.CA) has a support level at 1.67 and a resistance level at 1.7. Check the full technical report for a detailed analysis of ARCH.CA support and resistance levels.
Should I buy ARCH BIOPARTNERS INC (ARCH.CA) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of ARCH.CA, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of ARCH.CA, evaluating the profitability, health, valuation and growth aspects
- ARCH BIOPARTNERS INC (ARCH.CA) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- ARCH BIOPARTNERS INC (ARCH.CA) Sales and EPS estimates to see what analysts future expectations are.
- ARCH BIOPARTNERS INC (ARCH.CA) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- ARCH BIOPARTNERS INC (ARCH.CA) Insider and Institutional Ownership to learn about the owners and their transactions.
- ARCH BIOPARTNERS INC (ARCH.CA) Stock Chart to make your own analysis
- ARCH BIOPARTNERS INC (ARCH.CA) Latest news and press-releases to stay up to date.
Does ARCH BIOPARTNERS INC (ARCH.CA) stock pay dividends?
ARCH.CA does not pay a dividend.
When does ARCH BIOPARTNERS INC (ARCH.CA) report earnings?
ARCH BIOPARTNERS INC (ARCH.CA) will report earnings on 2026-01-26.
What is the Price/Earnings (PE) ratio of ARCH BIOPARTNERS INC (ARCH.CA)?
ARCH BIOPARTNERS INC (ARCH.CA) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.05).
ARCH.CA Technical Analysis
ChartMill assigns a technical rating of 1 / 10 to ARCH.CA. When comparing the yearly performance of all stocks, ARCH.CA turns out to be only a medium performer in the overall market: it outperformed 41.01% of all stocks.
ARCH.CA Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to ARCH.CA. Both the profitability and financial health of ARCH.CA have multiple concerns.
ARCH.CA Financial Highlights
Over the last trailing twelve months ARCH.CA reported a non-GAAP Earnings per Share(EPS) of -0.05. The EPS increased by 47.21% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -551.08% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
ARCH.CA Forecast & Estimates
7 analysts have analysed ARCH.CA and the average price target is 3.57 CAD. This implies a price increase of 112.5% is expected in the next year compared to the current price of 1.68.